Acknowledgements
We are grateful to the patient and his family for their participation in
this study. We thank Beijing McGinow Technology Co. for their technical
support in gene sequencing and data analysis. We would also like to
acknowledge the clinical staff of the Endocrinology Department of
Beijing Children’s Hospital and the Neonatal Department of Capital
Institute of Pediatrics for their assistance in the present study.
[1] Shepherd, M.et al.Systematic Population Screening, Using
Biomarkers and Genetic Testing, Identifies 2.5% of the U.K.Pediatric
Diabetes Population With Monogenic Diabetes.Diabetes Care, 39:
1879-1888, doi:10.2337/dc16-0645 (2016).
[2] Bansal, V.et al.Spectrum of mutations in monogenic diabetes
genes identified from high-throughput DNA sequencing of 6888
individuals. BMC medicine 15, 213, doi:10.1186/s12916-017-0977-3 (2017).
[3] Anik A, et al. Maturity-onset diabetes of the young(MODY): an
update[J].J Pediatr Endocrinol Metab, 2015, 28(34): 25l-263.
DOI:10.1515/jpem-2014-0384.
[4] Froguel P,Vaxillaire M. Monogenic diabetes in the young,
pharmacogenetics and relevance to multifactorial forms of type 2
diabetes.[J]. 2008, 29(3).
[5] Hattersley AT, SAW G, Polak M, et al. ISPAD clinical practice
consensus guidelines 2018: the diagnosis and management of monogenic
diabetes in children and adolescents[J]. Pediatr Diabetes, 2018,19
Suppl 27: 47‐63. DOI: 10.1111/pedi.12772
[6] FlannickJ,Beer NL,Bick AG,et al.Assessing the phenotypic effects
in the general population of rare variants in genes for a dominant
Mendelian form of diabetes[J].Nat Genet, 2013, 45(11):1380-1385.
[7] Bowman P, Flanagan S, Edghill E, et al. Heterozygous ABCC8
mutations are a cause of MODY[J].Diabetologia, 2012,55(1): 123-127.
[8] Bonnefond A, Philippe J, Durand E, et al. Whole-exome sequencing
and high through put genotyping identified KCNJ11 as the thirteenth MODY
gene[J].PLoS One,2012,7(6):e37423.
[9] Fajans SS, Bell GI, Polonsky KS (2001) Molecular mechanisms and
clinical pathophysiology of maturity-onset diabetes of the young.N Engl
J Med, 345(13):971–980
[10] Plengvidhya N, Kooptiwut S, Songtawee N, et al. PAX4 mutations
in Thais with maturity onset diabetes of the young[J]. J
ClinEndocrinol Metab, 2007, 92(7): 2821-2826.
[11] Brun T, Franklin I, St-Onge L, Biason-Lauber A, Schoenle EJ,
Wollheim CB et al (2004) The diabetes-linked transcription factor PAX4
promotes beta-cell proliferation and survival in rat and human islets. J
Cell Biol 167(6):1123–1135.
[12] Mansouri A, Goudreau G, Gruss P. Pax genes and their role in
organogenesis. Cancer Res, 1999;59: 1707–9.
[13] Antojenifer Panneerselvam, Arun Kannan, et al. PAX proteins and
their role in pancreas. Diabetes research and clinical practice
155(2019)107792;
[14] Sosa-Pineda B, ChowdhuryK, Torres M, et al. The Pax4 gene is
essential for differentiation of insulin-producing beta cells in the
mammalian pancreas[J]. Nature,1997,386(6623):399-402. DOI:
10.1038/386399a0
[15] Habener JF, Kemp DM, Thomas MK. 2005 Minireview transcriptional
regulation in pancreatic development. Endocrinology 146:1025–1034.
[16] Wang J, Elghazi L, Parker SE, Kizilocak H, Asano M, Sussel L,
Sosa-Pineda B 2004 The concerted activities of Pax4 and Nkx2.2 are
essential to initiate pancreatic β-cell differentiation. Dev Biol,
266:178 –189.
[17] Sosa-Pineda B, Chowdhury K, Torres M, Oliver G, Gruss P 1997
The Pax4 gene is essential for differentiation of insulin-producing β
cells in the mam-malian pancreas. Nature 386:399-402
[18] T Zhang, HW Wang, et al. Pax4 synergistically acts with Pdx1,
Ngn3 and MafA to induce HuMSCs to differentiate into functional
pancreatic β-cells. Experimental and Therapeutic Medicine. 2019, 18:
2592-2598.
[19] Marc Gregory Yu, Hillary A. Keenan, Hetal S. Shah, et al.
Residual β cell function and monogenic variants in long-duration type 1
diabetes patients. The Journal of Clinical Investigation.
2019;129(8):3252–3263.
[20] Jo W, Endo M, Ishizu K, et a1. A novel PAX4 mutation in a
Japanese patient with maturity-onset diabetes of the young[J].
Tohoku J Exp Med, 2011, 223(2): 113-118.
[21] Serena Pezzilli, Ornella Ludovico(2018), Insights From
Molecular Characterization of Adult Patients of Families With
Multigenerational Diabetes. Diabetes 2018;67:137–145
[22] Natalia Zubkova, Fatima Burumkulova2, et al. High frequency
of pathogenic and rare sequence variants in diabetes-related genes
among Russian patients with diabetes in pregnancy, Acta Diabetologica
2019,https://doi.org/10.1007/s00592-018-01282-6
[23] Aaron Chapla, Mahesh Doddabelavangala Mruthyunjaya, et al.
Maturity onset diabetes of the young in India – a distinctive mutation
pattern identified through targeted next-generation sequencing, Clinical
Endocrinology (2014), DOI: 10.1111/cen.12541
[24] Smith SB, Ee HC, Conners JR, German MS 1999 Paired-homeodomain
transcription factor PAX4 acts as a transcriptional repressor in early
pancreatic development. Mol Cell Biol, 19:8272–8280.